en

PRODUCT DETAIL

EXJADE 125 mg dispergovateľné tablety

Code 71796
MA number EU/1/06/356/007
Product Form: tbl dsp 252x125 mg (blis. PVC/PE/PVDC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 19 - ANTIDOTA, DETOXICANTIA
ATC:
V VARIOUS
V03 ALL OTHER THERAPEUTIC PRODUCTS
V03A ALL OTHER THERAPEUTIC PRODUCTS
V03AC Iron chelating agents
V03AC03 Deferasirox
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 17.12.2008
SmPC + PL: European Medicines Agency's database
Dokument: EXJADE_Kontrolny zoznam pre lekara.pdf  
Dokument: EXJADE_Prirucka pre lekarov.pdf  
Dokument: EXJADE_Prirucka pre pacienta.pdf  
Safety feature Yes
Data update: 30.07.2018
eu-flag.png sk-flag.png